請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18855
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 姜至剛(Chih-Kang Chiang) | |
dc.contributor.author | Yi-Ting Wu | en |
dc.contributor.author | 吳宜庭 | zh_TW |
dc.date.accessioned | 2021-06-08T01:37:54Z | - |
dc.date.copyright | 2020-09-03 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-08-18 | |
dc.identifier.citation | Part VIII. References 1. Murray, C.J. and A.D. Lopez, Measuring the global burden of disease. New England Journal of Medicine, 2013. 369(5): p. 448-457. 2. Rodriguez-Mañas, L. and L.P. Fried, Frailty in the clinical scenario. The Lancet, 2015. 385(9968): e7-e9. 3. Fried, L.P., et al., Frailty in older adults: evidence for a phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2001. 56(3): M146-M157. 4. Visser, M. and L.A. Schaap, Consequences of Sarcopenia. Clinics in Geriatric Medicine, 2011. 27(3): p. 387-399. 5. Marzetti, E., et al., Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol, 2013. 45(10): p. 2288-2301. 6. Morley, J.E., et al., Sarcopenia. Journal of Laboratory and Clinical Medicine, 2001. 137(4): p. 231-243. 7. Roubenoff, R., Sarcopenia and its implications for the elderly. European journal of clinical nutrition, 2000. 54(3): S40-S47. 8. Rom, O., et al., Lifestyle and sarcopenia—etiology, prevention, and treatment. Rambam Maimonides medical journal, 2012. 3(4): e0024. 9. Souza, V.A., et al., Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors. PLoS One, 2017. 12(4): e0176230. 10. Marcell, T.J., Review Article: Sarcopenia: Causes, Consequences, and Preventions. The Journals of Gerontology: Series A, 2003. 58(10): M911-M916. 11. Ziaaldini, M.M., et al., Biochemical Pathways of Sarcopenia and Their Modulation by Physical Exercise: A Narrative Review. Frontiers in Medicine, 2017. 4: 167. 12. Nozaki, T., et al., A novel in vitro model of sarcopenia using BubR1 hypomorphic C2C12 myoblasts. Cytotechnology, 2016. 68(5): p. 1705-1715. 13. Cervelli, M., et al., Skeletal Muscle Pathophysiology: The Emerging Role of Spermine Oxidase and Spermidine. Medical sciences (Basel, Switzerland), 2018. 6(1): 14. 14. Abmayr, S.M. and G.K. Pavlath, Myoblast fusion: lessons from flies and mice. Development, 2012. 139(4): 641. 15. Marroncelli, N., et al., HDAC4 regulates satellite cell proliferation and differentiation by targeting P21 and Sharp1 genes. Scientific Reports, 2018. 8(1): 3448. 16. Robertson, T., et al., Fusion between myogenic cells in vivo: an ultrastructural study in regenerating murine skeletal muscle. Journal of structural biology, 1990. 105(1-3): p. 170-182. 17. Snow, M.H., Myogenic cell formation in regenerating rat skeletal muscle injured by mincing I. A fine structural study. The Anatomical Record, 1977. 188(2): p. 181-199. 18. Robertson, T., J. Papadimitriou, and M. Grounds, Fusion of myogenic cells to the newly sealed region of damaged myofibres in skeletal muscle regeneration. Neuropathology and applied neurobiology, 1993. 19(4): p. 350-358. 19. Deato, M.D.E., et al., MyoD targets TAF3/TRF3 to activate myogenin transcription. Molecular cell, 2008. 32(1): p. 96-105. 20. Braun, T., et al., MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. Development, 1994. 120(11): 3083. 21. Olguin, H.C. and B.B. Olwin, Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Developmental Biology, 2004. 275(2): p. 375-388. 22. Cervelli, M., et al., Skeletal Muscle Pathophysiology: The Emerging Role of Spermine Oxidase and Spermidine. Medical Sciences, 2018. 6. 23. Carlson, M.E., M. Hsu, and I.M. Conboy, Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature, 2008. 454(7203): p. 528-32. 24. Roberts, A.B., et al., Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A, 1985. 82(1): p. 119-23. 25. Watabe, T. and K. Miyazono, Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res, 2009. 19(1): p. 103-15. 26. Travis, M.A. and D. Sheppard, TGF-β activation and function in immunity. Annu Rev Immunol, 2014. 32: p. 51-82. 27. Ignotz, R.A. and J. Massague, Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. Journal of Biological Chemistry, 1986. 261(9): p. 4337-4345. 28. Derynck, R. and R.J. Akhurst, Differentiation plasticity regulated by TGF-β family proteins in development and disease. Nature cell biology, 2007. 9(9): p. 1000-1004. 29. Shi, Y. and J. Massagué, Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus. Cell, 2003. 113(6): p. 685-700. 30. Branton, M.H. and J.B. Kopp, TGF-β and fibrosis. Microbes and Infection, 1999. 1(15): p. 1349-1365. 31. Serrano, A.L. and P. Muñoz-Cánoves, Regulation and dysregulation of fibrosis in skeletal muscle. Experimental cell research, 2010. 316(18): p. 3050-3058. 32. Cohn, R.D., et al., Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states. Nature medicine, 2007. 13(2): p. 204-210. 33. Sabatelli, P., et al., Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis. Matrix Biology, 2012. 31(3): p. 187-196. 34. Zanotti, S., S. Gibertini, and M. Mora, Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-β1 treatment. Cell and tissue research, 2010. 339(2): p. 397-410. 35. Wu, T.-T., W.-M. Li, and Y.-M. Yao, Interactions between Autophagy and Inhibitory Cytokines. International journal of biological sciences, 2016. 12(7): p. 884-897. 36. Iovino, S., et al., PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation. Cell death and differentiation, 2012. 19(7): p. 1127-1138. 37. Glick, D., S. Barth, and K.F. Macleod, Autophagy: cellular and molecular mechanisms. J Pathol, 2010. 221(1): p. 3-12. 38. Lahiri, V., W.D. Hawkins, and D.J. Klionsky, Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism. Cell Metab, 2019. 29(4): p. 803-826. 39. Cuervo, A.M. and E. Wong, Chaperone-mediated autophagy: roles in disease and aging. Cell Research, 2014. 24(1): p. 92-104. 40. Yang, Z. and D.J. Klionsky, Mammalian autophagy: core molecular machinery and signaling regulation. Current Opinion in Cell Biology, 2010. 22(2): p. 124-131. 41. Parzych, K.R. and D.J. Klionsky, An overview of autophagy: morphology, mechanism, and regulation. Antioxidants redox signaling, 2014. 20(3): p. 460-473. 42. Mizushima, N., T. Yoshimori, and Y. Ohsumi, The role of Atg proteins in autophagosome formation. Annual review of cell and developmental biology, 2011. 27: p. 107-132. 43. Zachari, M. and I.G. Ganley, The mammalian ULK1 complex and autophagy initiation. Essays Biochem, 2017. 61(6): p. 585-596. 44. Nazio, F., et al., mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nature Cell Biology, 2013. 15(4): p. 406-416. 45. Mercer, T.J., A. Gubas, and S.A. Tooze, A molecular perspective of mammalian autophagosome biogenesis. The Journal of biological chemistry, 2018. 293(15): p. 5386-5395. 46. Kim, K.H. and M.-S. Lee, Autophagy—a key player in cellular and body metabolism. Nature Reviews Endocrinology, 2014. 10(6): p. 322-337. 47. Liang, X.H., et al., Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999. 402(6762): p. 672-676. 48. Liang, C., et al., Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nature cell biology, 2006. 8(7): p. 688-698. 49. Cully, M., et al., Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer, 2006. 6(3): p. 184-192. 50. Martinez-Vicente, M. and A.M. Cuervo, Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol, 2007. 6(4): p. 352-61. 51. Harris, J., et al., T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity, 2007. 27(3): p. 505-517. 52. Cuervo, A.M., et al., Autophagy and aging: the importance of maintaining' clean' cells. Autophagy, 2005. 1(3): p. 131-140. 53. Shintani, T. and D.J. Klionsky, Autophagy in Health and Disease: A Double-Edged Sword. Science, 2004. 306(5698): p. 990-995. 54. Brookes, P.S., et al., Calcium, ATP, and ROS: a mitochondrial love-hate triangle. American Journal of Physiology-Cell Physiology, 2004. 287(4): C817-C833. 55. Gouspillou, G. and R.T. Hepple, Editorial: Mitochondria in Skeletal Muscle Health, Aging and Diseases. Frontiers in Physiology, 2016. 7: 446. 56. Takahashi, M. and D.A. Hood, Protein import into subsarcolemmal and intermyofibrillar skeletal muscle mitochondria differential import regulation in distinct subcellular regions. Journal of Biological Chemistry, 1996. 271(44): 27285-27291. 57. Arsalan Damirchi, P.B., Meysam Gholamali and Kamal Ranjbar Mitochondrial Biogenesis in Skeletal Muscle: Exercise and Aging. IntechOpen, 2012. doi: 10.5772/48411 58. Scarpulla, R.C., Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et biophysica acta, 2011. 1813(7): p. 1269-1278. 59. Osellame, L.D., T.S. Blacker, and M.R. Duchen, Cellular and molecular mechanisms of mitochondrial function. Best practice research. Clinical endocrinology metabolism, 2012. 26(6): p. 711-723. 60. Ni, H.M., J.A. Williams, and W.X. Ding, Mitochondrial dynamics and mitochondrial quality control. Redox Biol, 2015. 4: p. 6-13. 61. Tilokani, L., et al., Mitochondrial dynamics: overview of molecular mechanisms. Essays in Biochemistry, 2018. 62(3): p. 341-360. 62. Chang, C.-R. and C. Blackstone, Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Annals of the New York Academy of Sciences, 2010. 1201: p. 34-39. 63. Smirnova, E., et al., Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Molecular biology of the cell, 2001. 12(8): p. 2245-2256. 64. Zhan, M., et al., Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney International, 2013. 83(4): p. 568-581. 65. Lee, J.-Y., et al., MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. Journal of cell science, 2014. 127(22): p. 4954-4963. 66. Bonora, M., et al., Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature reviews. Cardiology, 2019. 16(1): p. 33-55. 67. Palikaras, K., et al., Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover. Pharmacol Ther, 2017. 178: p. 157-174. 68. Youle, R.J. and D.P. Narendra, Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology, 2011. 12(1): p. 9-14. 69. Gustafsson, A.B. and G.W. Dorn, 2nd, Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process. Physiol Rev, 2019. 99(1): p. 853-892. 70. Villa, E., et al., Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells. Cell Reports, 2017. 20(12): p. 2846-2859. 71. Burnes, L.A., et al., Enhanced muscle fatigue occurs in male but not female ASIC3−/− mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008. 294(4): R1347-R1355. 72. Mann, C.J., et al., Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle, 2011. 1(1): 21. 73. Vaidya, T.B., et al., Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1. Mol Cell Biol, 1989. 9(8): p. 3576-9. 74. Brennan, T.J., et al., Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. Proc Natl Acad Sci U S A, 1991. 88(9): p. 3822-6. 75. Yang, X., et al., HMGB1/autophagy pathway mediates the atrophic effect of TGF-beta1 in denervated skeletal muscle. Cell Commun Signal, 2018. 16(1): p. 97. 76. Mizushima, N., T. Yoshimori, and B. Levine, Methods in mammalian autophagy research. Cell, 2010. 140(3): p. 313-26. 77. McMillan, E.M. and J. Quadrilatero, Autophagy is required and protects against apoptosis during myoblast differentiation. Biochem J, 2014. 462(2): p. 267-77. 78. Jokl, E.J. and G. Blanco, Disrupted autophagy undermines skeletal muscle adaptation and integrity. Mamm Genome, 2016. 27(11-12): p. 525-537. 79. Palikaras, K., E. Lionaki, and N. Tavernarakis, Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol, 2018. 20(9): p. 1013-1022. 80. Melser, S., J. Lavie, and G. Bénard, Mitochondrial degradation and energy metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015. 1853(10, Part B): p. 2812-2821. 81. Tiano, J.P., D.A. Springer, and S.G. Rane, SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) during exercise. J Biol Chem, 2015. 290(12): p. 7671-84. 82. Hoffmann, C., et al., The effect of differentiation and TGFbeta on mitochondrial respiration and mitochondrial enzyme abundance in cultured primary human skeletal muscle cells. Sci Rep, 2018. 8(1): p. 1-12. 83. Chowdhury, Subir R., et al., Simultaneous evaluation of substrate-dependent oxygen consumption rates and mitochondrial membrane potential by TMRM and safranin in cortical mitochondria. Bioscience Reports, 2016. 36(1): e00286 84. Dam, A.D., A.S. Mitchell, and J. Quadrilatero, Induction of mitochondrial biogenesis protects against caspase-dependent and caspase-independent apoptosis in L6 myoblasts. Biochim Biophys Acta, 2013. 1833(12): p. 3426-3435. 85. Perelman, A., et al., JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Disease, 2012. 3(11): e430-e430. 86. Gottlieb, E., et al., Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ, 2003. 10(6): p. 709-17. 87. Priault, M., et al., Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differentiation, 2005. 12(12): p. 1613-1621. 88. Elmore, S.P., et al., The mitochondrial permeability transition initiates autophagy in rat hepatocytes. Faseb j, 2001. 15(12): p. 2286-7. 89. Twig, G., et al., Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo j, 2008. 27(2): p. 433-46. 90. Twig, G. and O.S. Shirihai, The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal, 2011. 14(10): p. 1939-51. 91. Koltai, E., et al., Age-associated declines in mitochondrial biogenesis and protein quality control factors are minimized by exercise training. Am J Physiol Regul Integr Comp Physiol, 2012. 303(2): R127-34. 92. Crane, J.D., et al., The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol Sci Med Sci, 2010. 65(2): p. 119-28. 93. Backes, S., et al., Tom70 enhances mitochondrial preprotein import efficiency by binding to internal targeting sequences. J Cell Biol, 2018. 217(4): p. 1369-1382. 94. Cho, D.H., T. Nakamura, and S.A. Lipton, Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci, 2010. 67(20): p. 3435-47. 95. Viña, J., et al., Mitochondrial biogenesis in exercise and in ageing. Advanced Drug Delivery Reviews, 2009. 61(14): p. 1369-1374. 96. Alway, S.E., J.S. Mohamed, and M.J. Myers, Mitochondria Initiate and Regulate Sarcopenia. Exercise and sport sciences reviews, 2017. 45(2): p. 58-69. 97. Leduc-Gaudet, J.-P., et al., Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice. Oncotarget, 2015. 6(20): p. 17923-17937. 98. Ghavami, S., et al., Autophagy is a regulator of TGF-β 1-induced fibrogenesis in primary human atrial myofibroblasts. Cell death disease, 2015. 6(3): e1696-e1696. 99. Chang, K., et al., TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2. Autophagy, 2019: p. 1-16. 100. Mukherjee, P., S.L. Winter, and M.G. Alexandrow, Cell cycle arrest by transforming growth factor β1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction. Molecular and cellular biology, 2010. 30(3): p. 845-856. 101. Krstić, J., et al., Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression. Oxidative medicine and cellular longevity, 2015. 2015: 654594 102. Liu, R.-M. and L.P. Desai, Reciprocal regulation of TGF-β and reactive oxygen species: a perverse cycle for fibrosis. Redox biology, 2015. 6: p. 565-577. 103. Liu, Z., et al., Transforming growth factor β (TGFβ) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation. Journal of Biological Chemistry, 2019. 294(9): p. 3137-3151. 104. Burks, T.N. and R.D. Cohn, Role of TGF-β signaling in inherited and acquired myopathies. Skeletal muscle, 2011. 1(1): p. 1-13. 105. Chen, J.L., et al., The TGF-β signalling network in muscle development, adaptation and disease, in Growth Factors and Cytokines in Skeletal Muscle Development, Growth, Regeneration and Disease. 2016, Springer. p. 97-131. 106. Yoon, Y.-S., et al., TGF β1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene, 2005. 24(11): p. 1895-1903. 107. Dimeloe, S., et al., Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells. Science signaling, 2019. 12(599): eaav3334. 108. Casalena, G., I. Daehn, and E. Bottinger, Transforming growth factor-β, bioenergetics, and mitochondria in renal disease. Seminars in nephrology, 2012. 32(3): p. 295-303. 109. Romanello, V., et al., Mitochondrial fission and remodelling contributes to muscle atrophy. The EMBO journal, 2010. 29(10): p. 1774-1785. 110. VanderVeen, B.N., D.K. Fix, and J.A. Carson, Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation. Oxid Med Cell Longev, 2017. 2017: 3292087. 111. White, J.P., et al., IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+mouse. Skeletal Muscle, 2012. 2(1): 14. 112. Zhang, Y., et al., MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Molecular and Cellular Endocrinology, 2013. 381(1): p. 230-240. 113. Bohm, A., et al., TGF-beta Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle. Diabetes, 2016. 65(10): p. 2849-61. 114. Baechler, B.L., D. Bloemberg, and J. Quadrilatero, Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy, 2019. 15(9): p. 1606-1619. 115. O'Leary, M.F., et al., Adaptive plasticity of autophagic proteins to denervation in aging skeletal muscle. American Journal of Physiology-Cell Physiology, 2013. 304(5): C422-C430. 116. Sin, J., et al., Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts. Autophagy, 2016. 12(2): p. 369-80. 117. Cheng, Y.-H., The Roles of TGFβ1-conditioned C2C12 Extracellular Vesicles in Myogenesis. Graduate Institute of Toxicology, College of Medicine, National Taiwan University Master Thesis, 2019: p. 1-80. 118. Wang, J., et al., MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity. Cell death disease, 2015. 6(3): e1677-e1677. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18855 | - |
dc.description.abstract | 肌少症為老化相關疾病,其特徵骨骼肌肉質量、力量及功能的下降。肌少症的發生不只影響生活品質,也是全因性死亡率和發病率的預測指標。因此,近年來許多研究探討肌肉流失過程中的參與的相關機制。先前研究指出:粒線體的生成、粒線體動態平衡及粒線體自噬在骨骼肌細胞分化過程中扮演重要的角色。乙型轉化生長因子(transforming growth factor-beta 1, TGF-β1)是參與共同調控老化的一種細胞激素,參與細胞分化、增殖與胞外基質產生等反應;然而,許多研究指出過多的TGF-β1與肌肉流失和纖維化有關。另外,在我們先前的研究中證實TGF-β1會抑制骨骼肌細胞分化,但其中透過的機制尚未明瞭,因此,本篇研究目的為探討肌肉細胞分化過程中TGF-β1抑制細胞分化的可能機制。首先,我們證實年老的老鼠肌肉中含有更高的TGF-β1 mRNA表達,並有較差的肌耐力表現。接著,在C2C12細胞實驗中利用LC3 turnover assay 證實TGF-β1會誘發細胞自噬,而且透過同時處理自噬體與溶酶體融合的抑制劑氯喹(chloroquine)說明TGF-β1抑制細胞分化的過程中autophagy flux被過度誘發但並未受到阻斷。由於粒線體功能異常被認為是老化所致的肌肉退化的主要原因且粒線體也是細胞自噬的受質之一,因此,我們進一步由特定螢光探針染色並以共軛焦螢光顯微鏡觀察後發現,TGF-β1增加細胞中粒線體與自噬小體的共定位,表示TGF-β1誘發粒線體自噬的現象。接著,在分化後三天的C2C12中以海馬儀測量粒線體功能,發現處理TGF-β1顯著降低耗氧率(oxygen consumption rate, OCR)及ATP的產生,並以JC-1染劑偵測發現其膜電位顯著低於控制組。為了探討其粒線體功能下降的原因,我們以西方墨點法證實在C2C12分離出的粒線體蛋白中,與粒線體生成及動態平衡相關的蛋白表現量降低。綜上所述,根據我們目前的研究結果顯示,TGF-β1可能是透過過度誘發的細胞自噬及粒線體自噬與抑制粒線體合成與動態平衡蛋白表現,而使粒線體功能下降。未來仍需要更多研究證實TGF-β1抑制肌肉細胞分化的機制,發展做為治療肌少症的治療的標的。 | zh_TW |
dc.description.abstract | Sarcopenia has been defined as an age-related disease that features loss of skeletal muscle mass, strength, and function. It not only affects the quality of lives, but also a predictor of all-cause mortality and morbidity. Thus, many studies focus on the skeletal muscle-specific mechanisms underlying muscle loss progression. Previous research has shown that mitochondrial biogenesis, dynamics and mitophagy, which means the selective degradation of mitochondria via autophagic pathways, contribute to the skeletal muscle cell differentiation. Many cytokines take part in the aging process, one of them is transforming growth factor-beta 1 (TGF-β1), which is a multifunctional growth factor participated in a variety of biological process such as cell differentiation, proliferation, and extracellular matrix production. However, aberrant TGF-β1 production or stimulation always correlated with muscle loss and fibrosis. Our previous study demonstrated that TGF-β1 impaired skeletal muscle myogenesis. However, underlying mechanisms of TGF-β1-induced myogenic impairment still not elucidated. In this study, we aim to investigate the mechanisms of TGF-β1-induced myogenic differentiation impairment. Here we confirmed that muscle from old mice increase the TGF-β1 mRNA expression while and the muscle endurance was lower compared with young mice. In C2C12 cells, TGF-β1 treatment induced completely autophagy by LC3 turnover assay through co-treatment with chloroquine, the inhibitor of the last stage autophagy. The results suggested that myogenesis inhibition might be associated with hyperactivated autophagy but not blocked and accumulative autophagy. Because mitochondrial dysfunction of skeletal muscle cells was considered as the main factor leading to age-dependent muscle degeneration, and mitochondria was also a subtract of autophagy. We further investigated whether TGF-β1 interfered mitophagy. We observed TGF-β1 increased the colocalization between mitochondria and autophagosome under confocal fluorescence microscopy, indicating that TGF-β1 induces mitophagy. Then, we assessed the mitochondrial function with Seahorse analyzer and confirm that TGF-β1 significantly declined the oxygen consumption rate and ATP production after exposure for 3 days in differentiation medium and enhanced the depolarization of mitochondrial membrane potential which was monitored by membrane potential sensitive dye JC-1. To explore the reason of mitochondrial dysfunction, the expression of mitochondrial biogenesis and dynamics related proteins were found to decrease in the mitochondrial fraction in TGF-β1-treated cells with immunoblotting. Based on the current finding, our results, at least in part, demonstrated that TGF-β1 impaired myogenesis through inducing hyperactivated autophagy/mitophagy, suppressing mitochondrial function and inhibiting the mitochondrial biogenesis and dynamics. Further studies are indicated to confirm the underlying mechanisms involved in the TGFβ1-induced myogenic impairment to find a potential therapy of sarcopenia. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T01:37:54Z (GMT). No. of bitstreams: 1 U0001-1808202013045300.pdf: 1986662 bytes, checksum: 912a0b3ac088c42777d8777e58d3d28d (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 口試委員會審定書 i 致謝 ii 中文摘要 iv Abstract VI List of Abbreviation VIII Contents 10 Part I. Introduction 1 1.1. Background 1 1.2. Sarcopenia 1 1.3. Skeletal muscle myogenesis 3 1.4. Role of Transforming Growth Factor β in Skeletal Muscle Development 4 1.5. TGF-β1 and autophagy 5 1.6. Mitochondrial dysfunction in skeletal muscle 8 1.6.1. Mitochondrial biogenesis 8 1.6.2. Mitochondrial dynamics 9 1.7. Mitophagy 10 1.7.1. PINK1–Parkin-mediated mitophagy 10 1.7.2. Parkin-independent mitophagy 11 Part II. Aims 12 Part III. Materials and Methods 13 3.1. Animals 13 3.2. RNA extraction and quantitative real-time PCR analysis 13 3.3. Muscle fatigue task 14 3.4. Cell culture and treatments 14 3.5. Mitochondria isolation 15 3.6. Immunoblotting analysis 16 3.7. Morphological analysis 17 3.8. Measurement of mitochondrial respiration capacity 18 3.9. Measurement of mitochondrial membrane potentials by JC-1 staining 18 3.10. Determination of mitophagy 19 3.11. Statistical analysis 20 Part IV. Results 21 4.1. TGF-β1 impairs myogenic differentiation of C2C12 cells. 21 4.2. TGF-β1 treatment induces complete autophagy during C2C12 differentiation 21 4.3. Roles of mitophagy in TGF-β1-induced myogenic impairment. 23 4.4. TGF-β1 impairs mitochondrial content and function. 23 4.5. Effect of TGF-β1 on mitochondrial biogenesis and dynamics in C2C12 mitochondrial fraction. 24 Part V. Discussions 26 Part VI. Conclusion 31 Part VII. Future perspectives 32 7.1 Assessment of Mitophagy 32 7.2 The effect of myomiR on mitochondrial function 32 Part VIII. References 33 Part IX. Figures 46 Figure 1 46 Figure 2 48 Figure 3 50 Figure 4 51 Figure 5 53 Figure 6 55 Figure 7 57 Part X. Supplementary figures 59 Supplementary figure 1 59 | |
dc.language.iso | zh-TW | |
dc.title | TGF-β1誘導的線粒體功能障礙與肌肉生成有關 | zh_TW |
dc.title | TGF-β1-induced Mitochondrial Dysfunction Implicated in the Myogenesis | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 碩士 | |
dc.contributor.author-orcid | 0000-7687-2323-1314 | |
dc.contributor.oralexamcommittee | 劉興華(Shing-Hwa Liu),吳鎮天(Cheng-Tien Wu),許美鈴(Meei-Ling Sheu) | |
dc.subject.keyword | 肌少症,乙型轉化生長因子,肌肉細胞生成,細胞自噬,粒線體,粒線體自噬, | zh_TW |
dc.subject.keyword | Sarcopenia,Transforming growth factor-beta 1,Myogenesis,Autophagy,Mitochondria,Mitophagy, | en |
dc.relation.page | 59 | |
dc.identifier.doi | 10.6342/NTU202003956 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2020-08-18 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-1808202013045300.pdf 目前未授權公開取用 | 1.94 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。